Segers, Annelise
Amsterdam UMC Location University of Amsterdam · University of Amsterdam
2 papers on CoChat
Most cited papers
- Verified · note
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study
Buller, H. R., Lensing, A. W. A., Prins, M. H., Agnelli, G., Cohen, A., Gallus, A. S., Misselwitz, F., Raskob, G., Schellong, S., & Segers, A. (2008) · Blood
Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms
Cited by 342
- Verified
Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging study
BULLER, H., DEITCHMAN, D., PRINS, M., & SEGERS, A. (2008) · Journal of Thrombosis and Haemostasis
Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms
Cited by 252
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free